The 14th edition of Telangana’s most prestigious biotech and pharma summit, BioAisa, will be held during February 6-8, 2017. About 1,500 delegates and 800 representatives from across 50 countries are expected to participate in the conference.

The prominent speakers including Paul Stoffels, Worldwide Chairman of Pharmaceuticals and Chief Scientific Officer, Johnson & Johnson, Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Novartis and Patrick Vallance, President Worldwide Pharmaceuticals, R&D – GSK, among others.

“In its journey of 14 years, BioAsia has emerged as the largest life science event in India and one of the pre-eminent meetings in Asia. BioAsia 2017 is expected to be bigger,’’ Shakthi Nagappan, Chief Executive Officer of BioAsia program said in a release issued. BioAsia 2016 had witnessed participation from around 1300 registered delegates from 50 countries. It also conducted around 1200 trade, partnership meetings.